Based in Riom in the Puy-de-Dôme department, Verdot IPS² designs and manufactures a complete range of purification equipment for the biopharmaceutical, pharmaceutical, cosmetics, and food industries (mainly chromatography columns and skids). This technology is critical for developing producing active ingredients for drugs, vaccines, and biotechnological products. Its customers are mainly major players in the pharmaceutical industry (Top 10 big pharma & subcontractors, French and international biotech firms).
With Capital Export’s support, Verdot IPS² will keep developing its product range and accelerate its international expansion, especially in China and North America, while continuing its sectoral diversification. Capital Export will also help Verdot IPS² strengthen its ESG policy. This approach is an integral part of the company’s strategy, which is already ahead of the curve in implementing and monitoring extra-financial issues (training, quality, employee safety, resource use, and environmental impact).
Capital Export led the transaction and created a pool of co-investors including Swen Capital, CEPAL Capital Developpement, and CELDA Capital Developpement.
The senior debt was underwritten by a regional banking pool of Caisses d’Epargne (Auvergne-Limousin, Loire-Drôme-Ardèche, Aquitaine-Poitou-Charentes, and Bretagne-Pays de Loire).